Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

New Zealand (NZX) Healthcare Sector Analysis

UpdatedSep 02, 2026
DataAggregated Company Financials
Companies14
  • 7D-1.5%
  • 3M14.4%
  • 1Y3.2%
  • YTD1.9%

Over the last 7 days, the Healthcare industry has remained flat, although notably Summerset Group Holdings gained 9.4%. As for the the longer term, the industry is up 3.8% over the past 12 months. As for the next few years, earnings are expected to grow by 20% per annum.

Sector Valuation and Performance

Has the New Zealand Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Wed, 02 Sep 2026NZ$36.0bNZ$20.7bNZ$905.6m16.2x39.7x1.7x
Fri, 31 Jul 2026NZ$34.4bNZ$19.9bNZ$824.9m16.8x41.7x1.7x
Sun, 28 Jun 2026NZ$32.8bNZ$20.3bNZ$831.3m15.5x39.4x1.6x
Tue, 26 May 2026NZ$29.5bNZ$20.1bNZ$395.9m23.8x74.6x1.5x
Thu, 23 Apr 2026NZ$31.8bNZ$19.9bNZ$451.0m17.9x70.5x1.6x
Sat, 21 Mar 2026NZ$31.7bNZ$19.8bNZ$449.6m18.1x70.6x1.6x
Mon, 16 Feb 2026NZ$33.1bNZ$18.4bNZ$537.0m19.9x61.7x1.8x
Wed, 14 Jan 2026NZ$36.0bNZ$18.3bNZ$535.0m21.3x67.3x2x
Fri, 12 Dec 2025NZ$35.0bNZ$18.1bNZ$531.5m21.2x65.8x1.9x
Sun, 09 Nov 2025NZ$35.7bNZ$18.0bNZ$578.9m19.6x61.7x2x
Tue, 07 Oct 2025NZ$34.8bNZ$17.8bNZ$574.3m19.5x60.6x2x
Thu, 04 Sep 2025NZ$34.6bNZ$17.5bNZ$570.0m18.6x60.6x2x
Sat, 02 Aug 2025NZ$35.6bNZ$17.6bNZ$571.9m19.2x62.3x2x
Mon, 30 Jun 2025NZ$35.2bNZ$17.4bNZ$567.6m15.7x62x2x
Wed, 28 May 2025NZ$35.4bNZ$17.3bNZ$720.8m17.2x49.2x2x
Fri, 25 Apr 2025NZ$33.0bNZ$17.1bNZ$651.4m15.8x50.7x1.9x
Sun, 23 Mar 2025NZ$31.9bNZ$17.4bNZ$657.9m17.6x48.4x1.8x
Tue, 18 Feb 2025NZ$36.2bNZ$18.3bNZ$735.6m16.7x49.2x2x
Thu, 16 Jan 2025NZ$36.7bNZ$18.2bNZ$728.4m14.8x50.4x2x
Sat, 14 Dec 2024NZ$35.6bNZ$18.2bNZ$733.9m12.4x48.5x2x
Mon, 11 Nov 2024NZ$38.0bNZ$18.2bNZ$968.0m17.9x39.3x2.1x
Wed, 09 Oct 2024NZ$36.3bNZ$18.2bNZ$966.8m19.2x37.5x2x
Fri, 06 Sep 2024NZ$37.2bNZ$18.0bNZ$962.2m20.8x38.7x2.1x
Sun, 04 Aug 2024NZ$34.3bNZ$17.5bNZ$973.2m19.6x35.3x2x
Tue, 02 Jul 2024NZ$29.9bNZ$17.5bNZ$973.6m16.7x30.7x1.7x
Thu, 30 May 2024NZ$30.2bNZ$17.3bNZ$1.2b16.5x25x1.7x
Sat, 27 Apr 2024NZ$29.8bNZ$17.4bNZ$1.3b23.5x23.2x1.7x
Mon, 25 Mar 2024NZ$29.6bNZ$17.3bNZ$1.3b24.6x23x1.7x
Wed, 21 Feb 2024NZ$28.7bNZ$16.5bNZ$1.1b17.5x25.5x1.7x
Fri, 19 Jan 2024NZ$29.0bNZ$16.6bNZ$1.1b22.8x25.6x1.7x
Sun, 17 Dec 2023NZ$28.5bNZ$16.7bNZ$1.1b23.4x25.2x1.7x
Tue, 14 Nov 2023NZ$28.0bNZ$16.5bNZ$1.1b25.5x25.3x1.7x
Thu, 12 Oct 2023NZ$27.9bNZ$16.3bNZ$1.1b31x25.3x1.7x
Sat, 09 Sep 2023NZ$28.3bNZ$16.5bNZ$1.1b29.6x25.8x1.7x
Price to Earnings Ratio

25.8x


Total Market Cap: NZ$28.3bTotal Earnings: NZ$1.1bTotal Revenue: NZ$16.5bTotal Market Cap vs Earnings and Revenue0%0%0%
New Zealand Healthcare Sector Price to Earnings3Y Average 45.5x202420252026
Current Industry PE
  • Investors are pessimistic on the New Zealander Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 40.1x which is lower than its 3-year average PE of 45.5x.
  • The industry is trading close to its 3-year average PS ratio of 1.8x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have declined 6.3% per year over the last three years.
  • Meanwhile revenues for these companies have grown 7.8% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the New Zealand Healthcare sector?

NZ Market-1.29%
Healthcare-1.55%
Pharma2.56%
Biotech2.08%
Medical Equipment-1.56%
Healthcare Services-1.84%
Industry PE
  • Investors are most optimistic about the Medical Equipment industry even though it's trading below its 3-year average PE ratio of 81.3x.
    • Analysts are expecting annual earnings growth of 13.5%, which is lower than the prior year's growth of 24.2% per year.
Forecasted Growth
  • Analysts are most optimistic on the Biotech industry, expecting annual earnings growth of 65% over the next 5 years.
  • In contrast, the Medical Equipment industry is expected to see its earnings grow by 13% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
SUM Summerset Group HoldingsNZ$8.477.6%
+NZ$146.3m		-22.6%PE6x
BLT BLIS TechnologiesNZ$0.02525.0%
+NZ$6.4m		38.9%PE46.2x
TAH Third Age Health ServicesNZ$4.658.1%
+NZ$3.5m		6.4%PE16.4x
MEE Me TodayNZ$0.08310.7%
+NZ$756.2k		27.7%PS1x
RUA Rua BioscienceNZ$0.0352.9%
+NZ$339.4k		-40.7%PS5x

Latest News

RAD
NZ$0.45
Radius Residential Care
7D
-4.8%
1Y
20.9%
SUM
NZ$8.47
Summerset Group Holdings
7D
7.6%
1Y
-22.6%
FPH
NZ$44.60
Fisher & Paykel Healthcare
7D
-0.1%
1Y
21.0%
Narrative Update • Aug 22

FPH: Conviction List Removal Will Set Up Higher 2027 Dividend Outlook

Analysts have raised their fair value estimate for Fisher & Paykel Healthcare from NZ$47.00 to NZ$51.00, reflecting updated assumptions on revenue growth, profit margin and future P/E multiples, while also considering its recent removal from Goldman Sachs' APAC Conviction List as part of a broader review by the Street. What’s in the News for Fisher & Paykel Healthcare Fisher & Paykel Healthcare issued revised earnings guidance for the 2027 financial year, with operating revenue now guided to a range of about $2.47b to $2.57b and net profit after tax to about $525m to $565m.
EBO
NZ$20.75
EBOS Group
7D
-5.9%
1Y
-36.0%
Analysis Article • Aug 21

EBOS Group Limited Just Missed Earnings - But Analysts Have Updated Their Models

It's been a good week for EBOS Group Limited ( NZSE:EBO ) shareholders, because the company has just released its...
RUA
NZ$0.035
Rua Bioscience
7D
2.9%
1Y
-40.7%
PHL
NZ$0.72
Promisia Healthcare
7D
-4.0%
1Y
60.0%
TAH
NZ$4.65
Third Age Health Services
7D
8.1%
1Y
6.4%
MEE
NZ$0.083
Me Today
7D
10.7%
1Y
27.7%
BLT
NZ$0.025
BLIS Technologies
7D
25.0%
1Y
38.9%
OCA
NZ$0.80
Oceania Healthcare
7D
-0.6%
1Y
20.5%
Narrative Update • Jun 26

OCA: Revised Assumptions Will Temper Expectations While Supporting Steady Future Earnings

Analysts have revised their fair value estimate for Oceania Healthcare from about NZ$0.84 to around NZ$0.72. This reflects updates to the discount rate, revenue growth, profit margin and future P/E assumptions used in their valuation work.